INO250117C15000
- 0.01
- 0.000.00%
Inovio Pharmaceuticals Newsroom
Inovio Pharma Is Maintained at Neutral by HC Wainwright & Co.
H.C. Wainwright Maintains Inovio Pharmaceuticals(INO.US) With Hold Rating, Cuts Target Price to $3
Express News | Inovio Pharmaceuticals Inc : H.c. Wainwright Cuts Target Price to $3 From $5
Inovio Pharmaceuticals Analyst Ratings
JMP Securities Maintains Inovio Pharmaceuticals(INO.US) With Buy Rating, Maintains Target Price $18
Inovio Pharmaceuticals' Strategic Position Bolstered by INO-3107 Breakthrough and Fast Track Designations
Why Inovio Pharmaceuticals (INO) Stock Is Skyrocketing
Moderna, Novavax and Other Vaccine Names Extend Gains Amid COVID/flu Concerns
Top 3 Health Care Stocks That Could Blast Off This Month
Catalyst Watch: Eyes on Electric Vehicle Deliveries, Retail Data and Housing Reads
Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
Catalyst Watch: Labor Pains for Amazon & Starbucks, Nasdaq Call-up for MicroStrategy and Pony AI Ratings
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gold Down Over 1%; Inovio Pharmaceuticals Shares Plummet
Top Midday Decliners
Inovio Pharmaceuticals Shares Touch 52-Week Low After $30M Offering
Crude Oil Gains Over 1%; RH Shares Jump On Strong Forecast
US Stocks Mixed; Broadcom Shares Surge On Upbeat Earnings
Why Inovio Pharmaceuticals (INO) Stock Is Down 40%
Wall Street Set to Open Higher Friday as Investors Shake Off Bad Week